Creative Biolabs Announced cd25 Monoclonal Antibody for Research Use

SHIRLEY, NY - Nov 19, 2019 - November 19, 2019, as a leading supplier in the recombinant antibody field, Creative Biolabs aims to provide high-quality services and products to clients in the academia and industry fields all over the world. Recently, Creative Biolabs released cd25 monoclonal antibody for research use. This product is applied in the immunoassay techniques such as: flow cytometry. With six-month development, scientists from Creative Biolabs had developed cd25 monoclonal antibody with high quality and professional processing procedures. However, this is used for research use, not for any clinical use.

CD25 is a cytokine which plays a significant role in the proliferation of T and B lymphocytes. The receptor of cd25 monoclonal antibody is a heterotrimeric protein complex with a gamma chain which is shared by interleukin 4 and interleukin 7. IL2RA, IL2R beta chain, and the IL2R gamma chain are composing of the high-affinity IL2 receptor. Homodimeric IL2RA chains are able to produce low-affinity receptor, homodimeric IL2RB chains are built to produce a medium-affinity receptor. The expression of IL2 in mature thymocytes is a single allele, representing an abnormal regulatory pattern that controls the precise expression of a single gene. IL2 is produced primarily by mature T cells. IL2 plays an important role as a growth factor, differentiation factor and cell death regulator. IL-2 stimulates the proliferation of B cells, enhances the activity of natural killer cells, and inhibits the formation of granulocyte macrophage colonies. Targeted disruption of a similar gene in mice leads to ulcerative colitis-like disease, suggesting that it plays a role in the immune response to antigen stimulation. Mutations in this gene are associated with a deficiency in interleukin 2 receptor alpha.

“the cd25 monoclonal antibody from Creative Biolabs will be more and more popular among clients and biotechnological market. Due to its high quality and professional procedures, anti cd25 monoclonal antibody can assist researchers in their biotech projects. With the aim of providing high-quality products and professional services, Creative Biolabs is commit to develop more and more useful services and products. We do believe that anti cd25 antibody which are developed from different sources, such as B cells of immunized animals, hybridoma, phage display library, will be another mile stone of Creative Biolabs.”said Dr. Ben, a senior scientist from R&D in Creative Biolabs.

“With the advanced platform, including cutting-edge hybridoma development and phage display platform, Creative Biolabs is able to produce the most comprehensive list of recombiant antibody products and extensive service portfolio which are at the most competitive price.” added Dr. Ben.

About Creative Biolabs

Since its establishment, Creative Biolabs has served more than 10 million clients from all over the world. Scientists from Creative Biolabs are dedicated to the treatment of a wide variety of diseases, such as immune disorders, cancers, infections and more. Building up a custom-service-centered business model is the finial target of Creative Biolabs. It is believed that Creative Biolabs can step upto another stage of biotechnological fields in recombinant antibody.